Maxwell Lea is Vice President, Corporate Development and Corporate Finance at DFB Pharmaceuticals, Inc., a Fort Worth, Texas based organization that invests in and operates a portfolio of healthcare businesses. He is responsible for DFB’s acquisition, licensing, and financing activities. He also leads the Business Development activities (strategic partnerships, new technology assessment) and International operations (sales & marketing in Canada, Europe & Latin America) for Healthpoint Biotherapeutics, one of DFB’s operating businesses that is an industry leader in the field of wound healing and soft tissue repair.
Prior to joining DFB, Maxwell was an investment banker with Bank of America Securities, where he was responsible for the origination, structuring and execution of capital raising and M&A transactions in a variety of industries. He has earned the Chartered Financial Analyst designation, and graduated with a Bachelor of Arts degree in Economics from Vanderbilt University and a Master of Business Administration from The Fuqua School of Business at Duke University.